Oxandrolone

ADVERTISEMENT

Identification

Molecular formula
C19H30O3
CAS Number
53-39-4
IUPAC Name
2-[(17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene)amino]oxyacetic acid
Molecular Weight
306.45g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.1710g/cm3
Synonyms
210411-48-6
Interesting facts

Interesting Facts about 2-[(17-Hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene)amino]oxyacetic acid

This compound, known for its complex structure and bioactivity, holds significant interest within the fields of medicinal and organic chemistry. Here are some fascinating insights:

  • Structural Complexity: The compound features a fused-ring system that includes a cyclopenta[a]phenanthrene moiety, characterized by a unique arrangement of carbon atoms that contributes to its stability and reactivity.
  • Biological Relevance: The presence of a hydroxyl group and an amino group suggests potential interactions with biological systems, making this compound a candidate for further studies in drug development and therapeutic applications.
  • Potential Uses: Compounds of this nature often demonstrate properties that may be beneficial in treating various diseases, particularly those with hormonal or metabolic implications, due to their steroid-like structure.
  • Synthetic Challenges: The intricate synthetic pathway required to produce this compound may present challenges but also offers opportunities for developing new synthetic methodologies.
  • Research Opportunities: Many compounds with similar frameworks are actively researched for their anti-inflammatory and anticancer properties, indicating that this compound could pave the way for new therapeutic agents.

As one delves into the study of this compound, its potential applications and structural intricacies become evident, illustrating the beauty of chemistry as a bridge between structure and function within the realm of medicinal chemistry.

ADVERTISEMENT